IP Library Granted Patent US 10,370,393
Granted Patent B2
US 10,370,393 · App. 15/959,986 · Granted Aug 6, 2019

Stereoretentive cross-coupling of boronic acids

Inventors: Martin D. Burke (Champaign, IL); Ian Crouch (Urbana, IL); Jonathan Lehmann (Urbana, IL); Andrea Palazzolo (Urbana, IL); Claire Simons (Urbana, IL)
Assignee: The Board of Trustees of the University of Illinois
C07F9/5022B01J31/2404C07B37/04C07F5/025C07F15/006C07F15/0066B01J2231/4277B01J2531/824
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,370,393
App. No.
15/959,986
Granted
Aug 6, 2019
Kind
B2
Abstract

The present disclosure provides tri-orthoalkylphenyl phosphine catalysts of formula I wherein A is CH2, C═O, or NR A ; R 1 is aryl, heteroaryl, isopropyl, tert-butyl, cycloalkyl, or heterocycloalkyl, wherein aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted; R 2 is H, (C 1 -C 8 )alkyl, (C 1 -C 8 )alkoxy, N(R A ) 2 , or an electron withdrawing group; and each R A is independently H or (C 1 -C 8 )alkyl; that are tuned electrically and sterically.

Claims (15)

1. A phosphine compound of Formula I:

wherein

A is CH 2 , C═O, or NR A ;

R 1 is aryl, heteroaryl, tert-butyl, cycloalkyl, or heterocycloalkyl, wherein aryl, heteroaryl, cycloalkyl and heterocycloalkyl are optionally substituted;

R 2 is H, (C 1 -C 8 )alkyl, (C 1 -C 8 )alkoxy, N(R A ) 2 , or an electron withdrawing group; and

each R A is independently H or (C 1 -C 8 )alkyl; wherein the electron withdrawing group is halo, trifluoromethyl, pentafluoroethyl, trifluoromethoxy, nitrile, nitro, CO 2 R A , C(O)N(R A ) 2 , SO 2 R A , SO 2 N(R A ) 2 , or P(O)[N(R A ) 2 ] 2 .

2. The phosphine compound of claim 1 wherein R 1 is aryl or (C 3 -C 8 )cycloalkyl, wherein aryl and (C 3 -C 8 )cycloalkyl are optionally monosubstituted or disubstituted.

3. A The phosphine compound of Formula II:

wherein

R 1 is phenyl or (C 3 -C 6 )cycloalkyl, wherein phenyl and (C 3 -C 6 )cycloalkyl are optionally monosubstituted or disubstituted; and

R 2 is H, (C 1 -C 5 )alkyl, (C 1 -C 5 )alkoxy, N(R A ) 2 , halo, trifluoromethyl, pentafluoroethyl, trifluoromethoxy, nitrile, nitro, CO 2 R A , or C(O)N(R A ) 2 ; and each R A is independently H or (C 1 -C 8 )alkyl.

4. The phosphine compound of claim 3 wherein R 2 is H, halo, trifluoromethyl, pentafluoroethyl, trifluoromethoxy, nitrile, nitro, CO 2 R A , or C(O)N(R A ) 2 .

5. The phosphine compound of claim 3 wherein the phosphine compound is phosphine compound of Formula III:

6. The phosphine compound of claim 5 wherein R 2 is H, methyl ethyl, methoxy, ethoxy, dimethylamine, diethylamine, halo, trifluoromethyl, pentafluoroethyl, trifluoromethoxy, nitrile, nitro, CO 2 R A , or C(O)N(R A ) 2 .

7. The phosphine compound of claim 3 wherein the phosphine compound is one of phosphine compounds IIIA-IIIC:

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2018
From: BURKE, MARTIN D.; CROUCH, IAN; LEHMANN, JONATHAN; PALAZZOLO, ANDREA; SIMONS, CLAIRE
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 046006/0283 →
CONFIRMATORY LICENSE Recorded May 11, 2018
From: UNIVERSITY OF ILLINOIS
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046139/0542 →
Continuity (3)
Provisional Application 62659258 · Apr 18, 2018
Provisional Application 62488332 · Apr 21, 2017
Related Publication 20180305381A1 · Oct 25, 2018